Cancer52 Annual Review 2023-2024

cancer52
Feb 13
1 min read

Cancer52 is pleased to submit their Annual Review for the financial year 2023-2024 to the Charity Commission. As ever it is an excellent opportunity to recall the progress made, alongside the Cancer52 membership, on behalf of people affected by rare and less common cancers.

Read the Annual Review

Recent Posts

See All

Cancer52 seeking a Strategy Consultant

Cancer52 will soon develop a new organisational strategy to guide our activities and goals from 2026 to 2029. We are looking for an...

Big Cancer52 Conversation, March 2025

Report cover of Improving diagnosis: Patient and clinician perspectives on increasing early diagnosis in rare and less common cancers.

Improving Diagnosis Report

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.